Vetigenics

Philadelphia, United States

Vetigenics discovers and develops antibody-based immunotherapies to treat cancer and chronic diseases in companion animals

$6.0M raised

Feb 2025

Seed

Top Investors

Newchip Accelerator

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Vetigenics raised?

Vetigenics has raised $6.0M in total funding. The most recent round was Seed. The last funding was announced in February 2025.

Who are Vetigenics's investors?

Vetigenics's investors include Newchip Accelerator.

Where is Vetigenics headquartered?

Vetigenics is headquartered in Philadelphia, United States.

What does Vetigenics do?

Vetigenics discovers and develops antibody-based immunotherapies to treat cancer and chronic diseases in companion animals

What stage is Vetigenics at?

Vetigenics is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated February 3, 2025.

MLA

"Vetigenics — Funding & Investors." VCBacked, February 3, 2025, https://www.vcbacked.co/company/vetigenics. Accessed June 4, 2026.

APA

VCBacked. (2025). Vetigenics — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/vetigenics

Wikipedia (cite web)

{{cite web |title=Vetigenics — Funding & Investors |url=https://www.vcbacked.co/company/vetigenics |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated February 3, 2025.